224 related articles for article (PubMed ID: 8618437)
21. Trisomy/tetrasomy 13 in seven cases of acute leukemia.
Sreekantaiah C; Baer MR; Morgan S; Isaacs JD; Miller KB; Sandberg AA
Leukemia; 1990 Nov; 4(11):781-5. PubMed ID: 2232892
[TBL] [Abstract][Full Text] [Related]
22. Recurrent cytogenetic abnormalities observed in complete remission of acute myeloid leukemia do not necessarily mark preleukemic cells.
Raynaud SD; Brunet B; Chischportich M; Bayle J; Gratecos N; Pesce A; Dujardin P; Flandrin G; Ayraud N
Leukemia; 1994 Feb; 8(2):245-9. PubMed ID: 8309249
[TBL] [Abstract][Full Text] [Related]
23. Trisomy 21 as a sole acquired abnormality in an adult Omani patient with CD7- and CD9-positive acute myeloid leukemia.
Udayakumar AM; Pathare AV; Muralitharan S; Alghzaly AA; Alkindi S; Raeburn JA
Arch Med Res; 2007 Oct; 38(7):797-802. PubMed ID: 17845902
[TBL] [Abstract][Full Text] [Related]
24. Bcl-2 protein expression in normal human bone marrow precursors and in acute myelogenous leukemia.
Porwit-MacDonald A; Ivory K; Wilkinson S; Wheatley K; Wong L; Janossy G
Leukemia; 1995 Jul; 9(7):1191-8. PubMed ID: 7543174
[TBL] [Abstract][Full Text] [Related]
25. t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy.
Yin CC; Cortes J; Barkoh B; Hayes K; Kantarjian H; Jones D
Cancer; 2006 Apr; 106(8):1730-8. PubMed ID: 16532439
[TBL] [Abstract][Full Text] [Related]
26. [Acute myeloid leukemia in children with Down syndrome].
Creutzig U; Ritter J; Ludwig WD; Niemeyer C; Reinisch I; Stollmann-Gibbels B; Zimmermann M; Harbott J
Klin Padiatr; 1995; 207(4):136-44. PubMed ID: 7564143
[TBL] [Abstract][Full Text] [Related]
27. Acute myelogenous leukemia with T-cell features.
Ribrag V; Bayle C; Brault P; Bodis S; Magherini E; Hayat M
Bull Cancer; 1992; 79(12):1165-71. PubMed ID: 1304836
[TBL] [Abstract][Full Text] [Related]
28. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
[TBL] [Abstract][Full Text] [Related]
29. Acute myeloid leukemia with minimal differentiation. A multiple parameter study.
Cohen PL; Hoyer JD; Kurtin PJ; Dewald GW; Hanson CA
Am J Clin Pathol; 1998 Jan; 109(1):32-8. PubMed ID: 9426515
[TBL] [Abstract][Full Text] [Related]
30. Morphologic immunophenotypic and cytogenetic patterns of adult acute myeloid leukemia in Saudi Arabia.
Roberts GT; Spence DG; Padmos MA; Sheth KV; Clink H; Ernst P
Leuk Res; 1992; 16(2):181-90. PubMed ID: 1545571
[TBL] [Abstract][Full Text] [Related]
31. [Clinical and immunophenotyping features of CD34-positive acute nonlymphoblastic leukemia].
Chen G; Qian L; Shen D
Zhonghua Nei Ke Za Zhi; 1995 Jan; 34(1):26-9. PubMed ID: 7541328
[TBL] [Abstract][Full Text] [Related]
32. Surface markers in adult acute myeloblastic leukemia: correlation of CD19+, CD34+ and CD14+/DR--phenotypes with shorter survival. Groupe d'Etude Immunologique des Leucémies (GEIL).
Solary E; Casasnovas RO; Campos L; Béné MC; Faure G; Maingon P; Falkenrodt A; Lenormand B; Genetet N
Leukemia; 1992 May; 6(5):393-9. PubMed ID: 1375696
[TBL] [Abstract][Full Text] [Related]
33. Relation of some cytochemical activities to the expression of CD34 marker in acute leukemia.
Klobusická M; Babusíková O; Hrivnáková A
Neoplasma; 1993; 40(5):309-14. PubMed ID: 7505888
[TBL] [Abstract][Full Text] [Related]
34. Acute myeloid leukemia, FAB M-1 microgranular variant: a multiparameter study.
Nguyen D; Brynes RK; Macaulay L; Kaplan B; Pinter-Brown LC
Hematol Pathol; 1989; 3(1):11-22. PubMed ID: 2545666
[TBL] [Abstract][Full Text] [Related]
35. Impact of trisomy 8 on cytobiological and clinical features of acute myelomonocytic and monocytic leukemia.
Tian L; Liu LB; Wang XB; Xiao J; Zou P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):364-8. PubMed ID: 15972121
[TBL] [Abstract][Full Text] [Related]
36. [Clinical analysis of HLA-DR-negative non-M3 AML].
Mori H; Sakai H; Sanada M; Shimamoto K; Sasaki S; Azuma R; Higuchi T; Harada H; Niikura H; Omine M; Fujita K; Takahashi N
Rinsho Ketsueki; 2007 Jul; 48(7):547-53. PubMed ID: 17695303
[TBL] [Abstract][Full Text] [Related]
37. Induction chemotherapy versus palliative treatment for acute myeloid leukemia in a consecutive cohort of elderly patients.
Colovic M; Colovic N; Radojkovic M; Stanisavljevic D; Kraguljac N; Jankovic G; Tomin D; Suvajdzic N; Vidovic A; Atkinson HD
Ann Hematol; 2012 Sep; 91(9):1363-70. PubMed ID: 22592651
[TBL] [Abstract][Full Text] [Related]
38. [Characteristics and Prognosis of 24 Cases of Primary Acute Myeloid Leukemia with Trisomy 8].
Wang JH; Yao B; Guo M; Qiao JH; Sun QY; Hu KX; Li BX; Yu CL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):655-61. PubMed ID: 27342486
[TBL] [Abstract][Full Text] [Related]
39. TdT+/nonlymphoid antigen+ acute leukemias: immunologic and karyotypic monitoring during therapy and at relapse suggests the transformation of a bipotential stem cell.
Paietta E; Gucalp R; Papenhausen P; Dutcher JP; Wiernik PH
Leukemia; 1989 Jul; 3(7):485-91. PubMed ID: 2733453
[TBL] [Abstract][Full Text] [Related]
40. Trisomy 21 as the sole acquired karyotypic abnormality in an adult patient with CD7-positive acute myeloid leukemia.
Kondo H; Kobayashi A; Iwasaki H
Cancer Genet Cytogenet; 2001 May; 127(1):77-9. PubMed ID: 11408071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
